| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 3.972 | 14.022 | 8.697 | 8.685 | 6.523 | - | 7.990 |
| Total Income - EUR | - | - | - | 3.972 | 14.025 | 10.620 | 12.569 | 15.257 | - | 9.434 |
| Total Expenses - EUR | - | - | - | 7.264 | 10.791 | 7.595 | 12.129 | 14.452 | - | 7.941 |
| Gross Profit/Loss - EUR | - | - | - | -3.292 | 3.234 | 3.025 | 440 | 805 | - | 1.493 |
| Net Profit/Loss - EUR | - | - | - | -3.332 | 2.941 | 2.874 | 309 | 612 | - | 764 |
| Employees | - | - | - | 1 | 1 | 0 | 1 | 1 | - | 1 |
Check the financial reports for the company - Bellis Bio Natura S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 1.427 | - | 872 |
| Current Assets | - | - | - | 3.972 | 4.707 | 8.871 | 9.963 | 9.577 | - | 11.518 |
| Inventories | - | - | - | 3.692 | 2.452 | 6.056 | 8.049 | 6.107 | - | 10.104 |
| Receivables | - | - | - | 0 | 1.476 | 1.807 | 1.620 | 2.039 | - | 974 |
| Cash | - | - | - | 280 | 779 | 1.008 | 294 | 1.432 | - | 440 |
| Shareholders Funds | - | - | - | -3.289 | -284 | 2.595 | 2.847 | 3.468 | - | -666 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | - | 40 |
| Debts | - | - | - | 7.261 | 4.992 | 5.369 | 7.116 | 7.536 | - | 13.056 |
| Income in Advance | - | - | - | 0 | 0 | 921 | 0 | 0 | - | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1032 - 1032" | |||||||||
| CAEN Financial Year |
1032
|
|||||||||
Comments - Bellis Bio Natura S.r.l.